logo
Baby Bunting Group (ASX:BBN) Will Want To Turn Around Its Return Trends

Baby Bunting Group (ASX:BBN) Will Want To Turn Around Its Return Trends

Yahoo15-02-2025

What trends should we look for it we want to identify stocks that can multiply in value over the long term? In a perfect world, we'd like to see a company investing more capital into its business and ideally the returns earned from that capital are also increasing. This shows us that it's a compounding machine, able to continually reinvest its earnings back into the business and generate higher returns. However, after briefly looking over the numbers, we don't think Baby Bunting Group (ASX:BBN) has the makings of a multi-bagger going forward, but let's have a look at why that may be.
For those who don't know, ROCE is a measure of a company's yearly pre-tax profit (its return), relative to the capital employed in the business. Analysts use this formula to calculate it for Baby Bunting Group:
Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)
0.069 = AU$17m ÷ (AU$332m - AU$91m) (Based on the trailing twelve months to June 2024).
Thus, Baby Bunting Group has an ROCE of 6.9%. In absolute terms, that's a low return and it also under-performs the Specialty Retail industry average of 17%.
View our latest analysis for Baby Bunting Group
Above you can see how the current ROCE for Baby Bunting Group compares to its prior returns on capital, but there's only so much you can tell from the past. If you're interested, you can view the analysts predictions in our free analyst report for Baby Bunting Group .
When we looked at the ROCE trend at Baby Bunting Group, we didn't gain much confidence. To be more specific, ROCE has fallen from 14% over the last five years. On the other hand, the company has been employing more capital without a corresponding improvement in sales in the last year, which could suggest these investments are longer term plays. It's worth keeping an eye on the company's earnings from here on to see if these investments do end up contributing to the bottom line.
To conclude, we've found that Baby Bunting Group is reinvesting in the business, but returns have been falling. And investors appear hesitant that the trends will pick up because the stock has fallen 41% in the last five years. All in all, the inherent trends aren't typical of multi-baggers, so if that's what you're after, we think you might have more luck elsewhere.
Like most companies, Baby Bunting Group does come with some risks, and we've found 1 warning sign that you should be aware of.
If you want to search for solid companies with great earnings, check out this free list of companies with good balance sheets and impressive returns on equity.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Undiscovered Gems in Middle East 3 Promising Stocks with Strong Potential
Undiscovered Gems in Middle East 3 Promising Stocks with Strong Potential

Yahoo

time17 minutes ago

  • Yahoo

Undiscovered Gems in Middle East 3 Promising Stocks with Strong Potential

As the Middle East markets experience a positive momentum with UAE shares rising and Dubai's benchmark index reaching its highest levels since 2008, investors are keenly watching the outcome of U.S.-China trade talks for potential impacts on global economic prospects. In this dynamic environment, identifying promising stocks often involves looking at companies with strong fundamentals and growth potential that can thrive amidst evolving market conditions. Name Debt To Equity Revenue Growth Earnings Growth Health Rating Alf Meem Yaa for Medical Supplies and Equipment NA 17.03% 18.37% ★★★★★★ MOBI Industry 6.50% 5.60% 24.00% ★★★★★★ Baazeem Trading 8.48% -2.02% -2.70% ★★★★★★ Nofoth Food Products NA 14.41% 31.88% ★★★★★★ Sure Global Tech NA 11.95% 18.65% ★★★★★★ Saudi Azm for Communication and Information Technology 2.07% 16.18% 21.11% ★★★★★★ Alfa Solar Enerji Sanayi ve Ticaret 38.29% -32.50% -4.61% ★★★★★☆ Waja 23.81% 98.44% 14.54% ★★★★☆☆ Saudi Chemical Holding 79.49% 16.57% 44.01% ★★★★☆☆ Izmir Firça Sanayi ve Ticaret Anonim Sirketi 43.01% 40.80% -34.83% ★★★★☆☆ Click here to see the full list of 223 stocks from our Middle Eastern Undiscovered Gems With Strong Fundamentals screener. We're going to check out a few of the best picks from our screener tool. Simply Wall St Value Rating: ★★★★☆☆ Overview: Gulermak Aglr Sanayi Insaat ve Taahhut A.S. operates in the construction and engineering industry, with a market cap of TRY43.71 billion. Operations: GLRMK generates revenue primarily from three geographical segments: East (TRY6.30 billion), West (TRY24.48 billion), and Turkey (TRY8.38 billion). The company experiences a deduction in total revenue due to eliminations amounting to TRY7.81 billion, impacting its overall financial performance. Gulermak Aglr Sanayi Insaat ve Taahhut, a notable player in the Middle East construction sector, has demonstrated robust earnings growth of 23.7% over the past year, outpacing the industry average of 16.1%. Despite a dip in Q1 2025 sales to TRY 6,835.73 million from TRY 10,004.92 million last year and net income falling to TRY 1,162.15 million from TRY 1,789.25 million, its annual performance remains strong with FY2024 sales at TRY 34.51 billion and net income at TRY 3.57 billion compared to previous figures of TRY 26.46 billion and TRY 1.64 billion respectively; this showcases its resilience amidst challenges. Take a closer look at Gulermak Aglr Sanayi Insaat ve Taahhut's potential here in our health report. Learn about Gulermak Aglr Sanayi Insaat ve Taahhut's historical performance. Simply Wall St Value Rating: ★★★★★★ Overview: Ray Sigorta Anonim Sirketi operates in the non-life insurance sector in Turkey with a market capitalization of TRY38.32 billion. Operations: Ray Sigorta Anonim Sirketi generates revenue primarily from accident insurance, contributing TRY10.46 billion, followed by fire insurance at TRY1.42 billion. The company's financial performance can be analyzed through its net profit margin trends over time. Ray Sigorta, a nimble player in the insurance sector, has seen its earnings grow 70.8% annually over the past five years, yet recent figures show a net income of TRY 812.65 million for Q1 2025, down from TRY 924.17 million last year. Despite this dip and lower profit margins at 12.8% compared to last year's 28.3%, the company remains debt-free and boasts high-quality earnings with positive free cash flow indicators. The company's basic earnings per share also slipped to TRY 5 from TRY 6 year-on-year, indicating some challenges amid robust industry growth rates of over double its own recent performance increase of 23.3%. Click here and access our complete health analysis report to understand the dynamics of Ray Sigorta Anonim Sirketi. Explore historical data to track Ray Sigorta Anonim Sirketi's performance over time in our Past section. Simply Wall St Value Rating: ★★★★☆☆ Overview: Kenon Holdings Ltd. is a company that owns, develops, and operates power generation facilities in Israel and the United States, with a market capitalization of ₪6.79 billion. Operations: Kenon Holdings generates revenue primarily through its subsidiaries, with OPC Israel contributing $625.96 million and CPV Group adding $134.35 million. Kenon Holdings, a nimble player in the Middle East market, has seen its debt to equity ratio improve significantly from 93% to 46.9% over five years, indicating stronger financial health. Despite becoming profitable recently with net income of US$12 million for Q1 2025 compared to US$8 million a year ago, its interest coverage remains tight at just 1.1x EBIT. The company's shares are trading at a substantial discount of 63.4% below estimated fair value and it recently completed share buybacks totaling US$48 million, reflecting confidence in its future prospects despite challenges with free cash flow positivity. Delve into the full analysis health report here for a deeper understanding of Kenon Holdings. Examine Kenon Holdings' past performance report to understand how it has performed in the past. Take a closer look at our Middle Eastern Undiscovered Gems With Strong Fundamentals list of 223 companies by clicking here. Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance. Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include IBSE:GLRMK IBSE:RAYSG and TASE:KEN. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

ASX Penny Stocks: Frontier Digital Ventures And 2 Other Promising Picks
ASX Penny Stocks: Frontier Digital Ventures And 2 Other Promising Picks

Yahoo

timean hour ago

  • Yahoo

ASX Penny Stocks: Frontier Digital Ventures And 2 Other Promising Picks

As the Australian market eases back into action after a brief hiatus, investors are keenly observing developments both locally and internationally, with trade talks and economic reports shaping the landscape. Despite being an older term, "penny stocks" continue to hold relevance for those looking to uncover growth opportunities in smaller or newer companies. With strong financial foundations, these stocks can offer attractive potential returns at lower price points, making them intriguing options for discerning investors. Name Share Price Market Cap Financial Health Rating EZZ Life Science Holdings (ASX:EZZ) A$1.50 A$70.76M ★★★★★★ GTN (ASX:GTN) A$0.65 A$124.05M ★★★★★★ IVE Group (ASX:IGL) A$2.57 A$396.25M ★★★★★☆ Southern Cross Electrical Engineering (ASX:SXE) A$1.67 A$441.56M ★★★★★★ Tasmea (ASX:TEA) A$3.08 A$725.72M ★★★★★☆ Regal Partners (ASX:RPL) A$2.25 A$756.37M ★★★★★★ Accent Group (ASX:AX1) A$1.845 A$1.11B ★★★★☆☆ Lindsay Australia (ASX:LAU) A$0.71 A$225.19M ★★★★☆☆ Bisalloy Steel Group (ASX:BIS) A$3.37 A$159.91M ★★★★★★ CTI Logistics (ASX:CLX) A$1.815 A$146.19M ★★★★☆☆ Click here to see the full list of 1,003 stocks from our ASX Penny Stocks screener. Below we spotlight a couple of our favorites from our exclusive screener. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Frontier Digital Ventures Limited is a private equity firm focused on investing in and developing online classifieds businesses in emerging markets, with a market cap of A$99.75 million. Operations: Frontier Digital Ventures generates revenue from its online classifieds businesses across various regions, with notable contributions from Infocasas (A$19.43 million), Fincaraiz (A$14.14 million), Encuentra24 (A$11.65 million), and Avito (A$7.66 million). Market Cap: A$99.75M Frontier Digital Ventures has a market cap of A$99.75 million and focuses on online classifieds in emerging markets, generating significant revenue from businesses like Infocasas and Fincaraiz. Despite being unprofitable, it maintains a strong cash position with short-term assets exceeding liabilities, allowing for over a year of runway based on current free cash flow. The company has reduced its debt-to-equity ratio significantly over five years and holds more cash than total debt. Recent board changes include the appointment of Patrick Grove as Director, which may influence strategic direction amidst high share price volatility. Jump into the full analysis health report here for a deeper understanding of Frontier Digital Ventures. Gain insights into Frontier Digital Ventures' future direction by reviewing our growth report. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Imugene Limited is a clinical stage immuno-oncology company in Australia that develops immunotherapies aimed at activating the immune system to treat and eradicate cancerous tumors, with a market cap of A$119.47 million. Operations: Imugene generates its revenue from the research, development, and commercialisation of health technologies, with reported earnings of -A$1.84 million. Market Cap: A$119.47M Imugene Limited, with a market cap of A$119.47 million, is a clinical-stage immuno-oncology company that remains pre-revenue, generating less than US$1 million. Despite being unprofitable and not expected to reach profitability in the next three years, Imugene's short-term assets significantly exceed both its short and long-term liabilities. The company has more cash than debt but faces a limited cash runway of 3-4 months based on past free cash flow estimates. Recent developments include its addition to the S&P/ASX Emerging Companies Index and presentations at industry conferences by CEO Leslie Chong. Dive into the specifics of Imugene here with our thorough balance sheet health report. Review our growth performance report to gain insights into Imugene's future. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Kingsgate Consolidated Limited is involved in the exploration, development, and mining of gold and silver mineral properties with a market capitalization of A$560.50 million. Operations: The company's revenue is primarily generated from its Chatree segment, which reported A$210.69 million. Market Cap: A$560.5M Kingsgate Consolidated, with a market cap of A$560.50 million, demonstrates strong financial performance in the penny stock category. The company has shown impressive earnings growth of 1203% over the past year, significantly outpacing industry averages. Its debt management is robust, with operating cash flow covering 69% of its debt and EBIT covering interest payments 17.2 times over. Recent announcements include a share buyback program aimed at enhancing shareholder value as part of its capital management strategy. However, while short-term liabilities are covered by assets, long-term liabilities remain uncovered by current short-term assets. Unlock comprehensive insights into our analysis of Kingsgate Consolidated stock in this financial health report. Explore Kingsgate Consolidated's analyst forecasts in our growth report. Unlock our comprehensive list of 1,003 ASX Penny Stocks by clicking here. Seeking Other Investments? We've found 17 US stocks that are forecast to pay a dividend yeild of over 6% next year. See the full list for free. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:FDV ASX:IMU and ASX:KCN. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

ASX Penny Stocks: Frontier Digital Ventures And 2 Other Promising Picks
ASX Penny Stocks: Frontier Digital Ventures And 2 Other Promising Picks

Yahoo

timean hour ago

  • Yahoo

ASX Penny Stocks: Frontier Digital Ventures And 2 Other Promising Picks

As the Australian market eases back into action after a brief hiatus, investors are keenly observing developments both locally and internationally, with trade talks and economic reports shaping the landscape. Despite being an older term, "penny stocks" continue to hold relevance for those looking to uncover growth opportunities in smaller or newer companies. With strong financial foundations, these stocks can offer attractive potential returns at lower price points, making them intriguing options for discerning investors. Name Share Price Market Cap Financial Health Rating EZZ Life Science Holdings (ASX:EZZ) A$1.50 A$70.76M ★★★★★★ GTN (ASX:GTN) A$0.65 A$124.05M ★★★★★★ IVE Group (ASX:IGL) A$2.57 A$396.25M ★★★★★☆ Southern Cross Electrical Engineering (ASX:SXE) A$1.67 A$441.56M ★★★★★★ Tasmea (ASX:TEA) A$3.08 A$725.72M ★★★★★☆ Regal Partners (ASX:RPL) A$2.25 A$756.37M ★★★★★★ Accent Group (ASX:AX1) A$1.845 A$1.11B ★★★★☆☆ Lindsay Australia (ASX:LAU) A$0.71 A$225.19M ★★★★☆☆ Bisalloy Steel Group (ASX:BIS) A$3.37 A$159.91M ★★★★★★ CTI Logistics (ASX:CLX) A$1.815 A$146.19M ★★★★☆☆ Click here to see the full list of 1,003 stocks from our ASX Penny Stocks screener. Below we spotlight a couple of our favorites from our exclusive screener. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Frontier Digital Ventures Limited is a private equity firm focused on investing in and developing online classifieds businesses in emerging markets, with a market cap of A$99.75 million. Operations: Frontier Digital Ventures generates revenue from its online classifieds businesses across various regions, with notable contributions from Infocasas (A$19.43 million), Fincaraiz (A$14.14 million), Encuentra24 (A$11.65 million), and Avito (A$7.66 million). Market Cap: A$99.75M Frontier Digital Ventures has a market cap of A$99.75 million and focuses on online classifieds in emerging markets, generating significant revenue from businesses like Infocasas and Fincaraiz. Despite being unprofitable, it maintains a strong cash position with short-term assets exceeding liabilities, allowing for over a year of runway based on current free cash flow. The company has reduced its debt-to-equity ratio significantly over five years and holds more cash than total debt. Recent board changes include the appointment of Patrick Grove as Director, which may influence strategic direction amidst high share price volatility. Jump into the full analysis health report here for a deeper understanding of Frontier Digital Ventures. Gain insights into Frontier Digital Ventures' future direction by reviewing our growth report. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Imugene Limited is a clinical stage immuno-oncology company in Australia that develops immunotherapies aimed at activating the immune system to treat and eradicate cancerous tumors, with a market cap of A$119.47 million. Operations: Imugene generates its revenue from the research, development, and commercialisation of health technologies, with reported earnings of -A$1.84 million. Market Cap: A$119.47M Imugene Limited, with a market cap of A$119.47 million, is a clinical-stage immuno-oncology company that remains pre-revenue, generating less than US$1 million. Despite being unprofitable and not expected to reach profitability in the next three years, Imugene's short-term assets significantly exceed both its short and long-term liabilities. The company has more cash than debt but faces a limited cash runway of 3-4 months based on past free cash flow estimates. Recent developments include its addition to the S&P/ASX Emerging Companies Index and presentations at industry conferences by CEO Leslie Chong. Dive into the specifics of Imugene here with our thorough balance sheet health report. Review our growth performance report to gain insights into Imugene's future. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Kingsgate Consolidated Limited is involved in the exploration, development, and mining of gold and silver mineral properties with a market capitalization of A$560.50 million. Operations: The company's revenue is primarily generated from its Chatree segment, which reported A$210.69 million. Market Cap: A$560.5M Kingsgate Consolidated, with a market cap of A$560.50 million, demonstrates strong financial performance in the penny stock category. The company has shown impressive earnings growth of 1203% over the past year, significantly outpacing industry averages. Its debt management is robust, with operating cash flow covering 69% of its debt and EBIT covering interest payments 17.2 times over. Recent announcements include a share buyback program aimed at enhancing shareholder value as part of its capital management strategy. However, while short-term liabilities are covered by assets, long-term liabilities remain uncovered by current short-term assets. Unlock comprehensive insights into our analysis of Kingsgate Consolidated stock in this financial health report. Explore Kingsgate Consolidated's analyst forecasts in our growth report. Unlock our comprehensive list of 1,003 ASX Penny Stocks by clicking here. Seeking Other Investments? We've found 17 US stocks that are forecast to pay a dividend yeild of over 6% next year. See the full list for free. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:FDV ASX:IMU and ASX:KCN. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store